Ipsen and IRLAB enter exclusive worldwide licensing agreement aimed to improve the lives of people living with Parkinson?s disease

Ipsen?s contacts | |
Investors | |
Craig Marks Vice President, Investor Relations +44 7584 349 193 | Adrien Dupin de Saint-Cyr Investor Relations Manager +33 6 64 26 17 49 |
Media | |
Jess Smith Senior Director, Global Communications, R&D and Business Development +44 7557 267 634 | ? ? ? ? |
IRLAB?s contacts | |
Nicholas Waters Chief Executive Officer +46?730 75 77 01 | Viktor Siewertz Chief Financial Officer +46?727 10 70 70 |